Antihypertensive effect of oral potassium aspartate supplementation in mild to moderate arterial hypertension

Conclusions. - A relatively low supplementation of 30 mmol/day of potassium as aspartate lowered office and 24-h ambulatory BP in subjects with mild to moderate essential hypertension. The antihypertensive effect was sustained throughout the day, and was greater in the patients with high basal urinary Na/K ratio.